HN0037

Cat. No.: HY-163529 Pureza: 99.46%: Ficha de datos
COA

SDS
Instrucciones de manejo
FAQs
Technical Support

HN0037 is a selective, orally active Helicase-primase inhibitor. HN0037 is mainly metabolized by CYP3A4. HN0037 inhibits HSV replication by targeting the viral helicase-primase complex, which consists of three proteins encoded by UL5 (helicase), UL52 (primase), and UL8 (scaffold protein that promotes primer synthesis).

Para uso exclusivo en investigación. No vendemos a pacientes.

HN0037 Estructura química

No. CAS : 2233566-79-3

Tamaño	Stock	Cantidad
1 mg	En stock	Estimated Time of Arrival: December 31
5 mg	En stock	Estimated Time of Arrival: December 31
10 mg	En stock	Estimated Time of Arrival: December 31
25 mg	En stock	Estimated Time of Arrival: December 31
50 mg	Obtener un presupuesto
100 mg	Obtener un presupuesto

or Consulta para venta a granel

* Seleccione Cantidad antes de agregar artículos.

This product is a controlled substance and not for sale in your territory.

Other Forms of HN0037:

(S)-HN0037 In-stock

Recomendaciones destacadas

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Ver todos los productos específicos de isoformas HSV:

Ver todas las isoformas

HSV-1 HSV-2 HSV

Ver todos los productos específicos de isoformas Cytochrome P450:

Ver todas las isoformas

CYP1 CYP2 CYP3 CYP4 CYP11 CYP17 Aromatase/CYP19A1 CYP26 CYP51 CYP1A2 CYP2D6 CYP2C9 CYP2C19 CYP3A CYP3A4 CYP17A1

Actividad biológica
Pureza y Documentación
Referencias
Revisión del cliente

Descripciòn

IC₅₀ & Target^[1]

CYP3A4

In Vitro

HN0037 is a potent, selective, orally bioavailable agent that exhibits activity against HSV infection in vitro^[1].
HN0037 inhibits HSV replication by targeting the viral helicase-primase complex^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Peso molecular

428.53

Fòrmula

C₂₀H₂₀N₄O₃S₂

No. CAS

2233566-79-3

Appearance

Solid

Color

White to off-white

SMILES

O=C(N(C1=NC(C)=C(S1)S(N)(=O)=O)C)[C@@H]2CC(C=CC(C3=CC=CC=N3)=C4)=C4C2

Envío

Room temperature in continental US; may vary elsewhere.

Almacenamiento

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

Pureza y Documentación

Purity: 99.46%

Select Batch:

Ficha de datos (267 KB) SDS (252 KB)

COA (249 KB) HNMR (242 KB) RP-HPLC (309 KB) LCMS (232 KB)

Instrucciones de manejo (2659 KB)

Referencias

[1]. Hou J, et al. Pharmacokinetics and Safety Study of HN0037, a Novel Anti-Human Herpes Simplex Virus Inhibitor, in Healthy Volunteers. Clin Pharmacol Drug Dev. 2022;11(12):1467-1473. [Content Brief]

HN0037 Related Classifications

Infection

Calculadora de molaridad
Calculadora de dilución

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass		Concentration		Volume		Molecular Weight *
	=		×		×

The dilution calculator equation

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)	×	Volume _(start)	=	Concentration _(final)	×	Volume _(final)
	×		=		×
C1		V1		C2		V2

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

HN00372233566-79-3HN 0037HN-0037HSVCytochrome P450Herpes simplex virusCYPsherpes simplex virushealthy volunteershelicase-primase inhibitorplaceboInhibitorinhibitorinhibit

Productos vistos recientemente:

Nombre del producto

Requested Quantity *

Nombre del solicitante *

Saludo

Direcciòn del E-mail *

Número de teléfono *

Department

Nombre de la Organizaciòn *

City

Provincia

Country or Region *

Observaciones

Nombre del producto

Lot #